Nobody Knew…Until the Diabetes Control and Complications Trial
The common belief for decades was that diligent monitoring of blood sugars and intensive insulin therapy had little consequence for…
The Power of the Patient Voice: Breakthrough T1D Video
In the words of Colin Dayan, M.D., Ph.D., professor of clinical diabetes and metabolism at Cardiff University: “Type 1 diabetes…
Tandem Control-IQ Improves T1D Management in Children Ages 6 and Up
A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system—which…
Breakthrough T1D Researchers Develop a Combined Risk Score to Predict Which Children Develop T1D
Type 1 diabetes (T1D) can be hard to predict in high risk children. Testing for the presence of T1D autoantibodies—antibodies…
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (featuring a “Happy Hour” with Dr. Aaron Kowalski)
At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the…
Dr. Jane Buckner Discusses Hydroxychloroquine T1D Prevention Study
Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.
At the Front Lines in COVID-19: Breakthrough T1D-Funded Scientist’s Company Developing a Vaccine
With coronavirus closing schools and forcing so many people to stay inside or wear facemasks every time they step outdoors,…
Zucara Faces “Valley of Death,” and Comes Out Triumphant
Low blood sugar, called hypoglycemia, is a real fear for people with type 1 diabetes (T1D). Although there are rescue…
Breakthrough T1D Awards World-Renowned T1D Researchers
Breakthrough T1D is honored to recognize five leading international researchers whose work has and is transforming type 1 diabetes (T1D)…
Universal Screening for Type 1 Diabetes: Its Time has Come?
Universal screening for type 1 diabetes (T1D) is a priority for Breakthrough T1D, but the cost versus benefits remain unclear.…
